| Related LncRNAs | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| ID | lncRNA Name | Disease | Method | Sample | Expression pattern | Dysfunction type | Description | PMID | Source |
| EL0250 | Bvht | cardiovascular disease | N/A | N/A | N/A | expression | Here, we identified Braveheart (Bvht), a heart-associated lncRNA in mouse. Using multiple embryonic stem cell (ESC) differentiation strategies, we show that Bvht is required for progression of nascent mesoderm toward a cardiac fate. | 23352431 | LncRNADisease |
| EL0289 | CDKN2B-AS1 | cardiovascular disease | N/A | N/A | N/A | mutation | Recent studies showed that single nucleotide polymorphisms (rs3217992, A>G;rs1063192, C>T) mapping in the vicinity of ANRIL are linked to a wide spectrum of conditions, including cardiovascular disease, ischemic stroke, type 2 diabetes, frailty and Alzheimer's disease. | 20716961 | LncRNADisease |
| EL0289 | CDKN2B-AS1 | cardiovascular disease | N/A | N/A | N/A | expression | ANRIL is a recently discovered long non-coding RNA encoded in the chromosome 9p21 region. This locus is a hotspot for disease-associated polymorphisms, and it has been consistently associated with cardiovascular disease, and more recently with several cancers, diabetes, glaucoma, endometriosis among other conditions. | 23104877 | LncRNADisease |
| EL0289 | CDKN2B-AS1 | cardiovascular disease | N/A | N/A | N/A | regulation | Recently, ANRIL, a multi-exonic lncRNA, has been shown to be implicated in epigenetic modulation in cardiac development and adult heart and also it has been associated with a locus implicated in cardiovascular disease. | 24113581 | LncRNADisease |
| EL0289 | CDKN2B-AS1 | cardiovascular disease | N/A | N/A | N/A | mutation | Aberrant ANRIL transcripts and mutations were associated with cardiovascular disease and cancer . | 24531795 | LncRNADisease |
| EL0289 | CDKN2B-AS1 | cardiovascular disease | N/A | N/A | N/A | mutation | Aberrant ANRIL transcripts and mutations were associated with cardiovascular disease and cancer . | 24531795 | LncRNADisease |
| EL0569 | HIF1A-AS1 | Cardiovascular disease | N/A | N/A | N/A | N/A | Clopidogrel reduces apoptosis and promotes proliferation of human vascular endothelial cells induced by palmitic acid via suppression of the long non-coding RNA HIF1A-AS1 in vitro. | 25761653 | LncRNADisease |
| EL1006 | NPPA-AS1 | cardiovascular disease | N/A | N/A | N/A | N/A | The NPPA-AS lncRNA has been shown to be a modulator of the alternative splicing of the NPPA gene. This lncRNA thus has potential to be involved in cardiovascular disease | 22817756 | LncRNADisease |